Those results, expected in 2026, will likely confirm and potentially extend the Phase 2 findings given the consistency of dose-response data
Semaglutide works by slowing stomach emptying and signaling fullness to your brain, which means your relationship with food fundamentally changes during treatment
95% CI, 0.60-1.02) in the participants who were taking GLP-1s in the study
However, semaglutide remains a highly effective and FDA-approved option for weight loss and diabetes management
This hormone dependence, along with the fact that exogenous influences are major risk factors for prostate cancer, make the prostate a likely target of harmful actions from EDCs
Why Specialized Training Matters Working with pediatric GLP-1 patients isnt just about understanding the medicationsits about navigating a complex intersection of medical, nutritional, psychological, and family dynamics